<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Lorentsson HJN</submitter><funding>Copenhagen University</funding><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>Tuberculosis disease (TB) and tuberculosis infection (TBI) have been associated with increased risk of cardiovascular disease which may be connected to infection-related haemostatic changes. It is unknown if treatment of Mycobacterium tuberculosis influences haemostasis. Here, we assessed if TB or TBI treatment affects thrombelastography (TEG)-assessed haemostasis.&lt;h4>Methods&lt;/h4>Individuals with TB or TBI were included from a TB outpatient clinic in Copenhagen, Denmark. Patients treated with antithrombotic medication or systemic immunosuppressants were excluded. TEG analysis was performed before and after TB/TBI treatment using the TEG&lt;sup>®&lt;/sup>6s analyser to provide data on the reaction time of clot initiation (R) (min), the speed of clot formation (K) </pubmed_abstract><journal>Thrombosis journal</journal><pagination>54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11201340</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study.</pubmed_title><pmcid>PMC11201340</pmcid><pubmed_authors>Jensen SG</pubmed_authors><pubmed_authors>Clausen CR</pubmed_authors><pubmed_authors>Hagelqvist PG</pubmed_authors><pubmed_authors>Krogh-Madsen R</pubmed_authors><pubmed_authors>Vilsboll T</pubmed_authors><pubmed_authors>Knop FK</pubmed_authors><pubmed_authors>Johansson PI</pubmed_authors><pubmed_authors>Faurholt-Jepsen D</pubmed_authors><pubmed_authors>Ravn P</pubmed_authors><pubmed_authors>Lorentsson HJN</pubmed_authors><pubmed_authors>Hansen KB</pubmed_authors></additional><is_claimable>false</is_claimable><name>The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study.</name><description>&lt;h4>Background and objective&lt;/h4>Tuberculosis disease (TB) and tuberculosis infection (TBI) have been associated with increased risk of cardiovascular disease which may be connected to infection-related haemostatic changes. It is unknown if treatment of Mycobacterium tuberculosis influences haemostasis. Here, we assessed if TB or TBI treatment affects thrombelastography (TEG)-assessed haemostasis.&lt;h4>Methods&lt;/h4>Individuals with TB or TBI were included from a TB outpatient clinic in Copenhagen, Denmark. Patients treated with antithrombotic medication or systemic immunosuppressants were excluded. TEG analysis was performed before and after TB/TBI treatment using the TEG&lt;sup>®&lt;/sup>6s analyser to provide data on the reaction time of clot initiation (R) (min), the speed of clot formation (K) </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-06-01T11:31:00.573Z</modification><creation>2024-10-15T14:37:08.101Z</creation></dates><accession>S-EPMC11201340</accession><cross_references><pubmed>38918780</pubmed><doi>10.1186/s12959-024-00625-4</doi></cross_references></HashMap>